W. Wehrli

2.9k citations

48 papers · 2.3k indexed · h-index 22

Impact in

Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria

Papers in

Molecular Medicine 6
- Antibiotic Resistance in Bacteria 6
Toxicology 3

Co-authors: M. Staehelin F. Knüsel H. Rogg Bruce C. Baguley Karl Schmid Alfred R. Schuerch T. Reichstein J. Nüesch
Journals: Helvetica Chimica Acta (10 papers)Journal of the American Chemical Society (5 papers)European Journal of Biochemistry (5 papers)The Journal of Antibiotics (4 papers)Biochemistry (3 papers)
Partner nations: Switzerland New Zealand France

In The Last Decade

W. Wehrli

48 papers receiving 2.0k citations

Peers

Replace L A Collins with:

L A Collins United States

Béatrice Cameron France

Fritz Reusser United States

Jean‐Michel Jault France

Kuni Takayama United States

F. Knüsel Switzerland

H. Vanden Bossche Belgium

Sanjib Bhakta United Kingdom

Elias K. Manavathu United States

Gary R. Eldridge United States

W. Wehrli relative to L A Collins United States L A Collins's profile →

Citations per field

00.5×1.6×

L A Collins · 1×

×1.6 169/108

TOXIC

×1.4 223/154

MM

×1.5 1k/880

MB

×0.4 348/971

ID

×1.2 290/252

PHARM

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by W. Wehrli

Since Specialization

Citations

This map shows the geographic impact of W. Wehrli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Wehrli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Wehrli more than expected).

Fields of papers citing papers by W. Wehrli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Wehrli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Wehrli. The network helps show where W. Wehrli may publish in the future.

Co-authorship network

The 25 scholars most cited alongside W. Wehrli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W. Wehrli Line = papers co-authored together W. Wehrli links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Resistance of Escherichia coli to rifampicin and sorangicin A - a comparison. The Journal of Antibiotics ·G.Y. Osmanova, Li-zhong Hu, Renate Solf, Klaus Vosbeck, J. Gruner, W. Wehrli	1990	18
2	Root induction on several Solanaceae species by Agrobacterium rhizogenes and the determination of root tropane alkaloid content Plant Cell Reports ·Diana Lorena Fernández Armijos, 庞妍娇, W. Wehrli	1988	27
3	Highly Efficient Uptake of a Rifamycin Derivative via the FhuA-TonB-dependent Uptake Route in Escherichia coli Microbiology ·A. P. Pugsley, William T. Zimmerman, W. Wehrli	1987	36
4	CGP 4832, a new semisynthetic rifamycin derivative highly active against some gram-negative bacteria. The Journal of Antibiotics ·W. Wehrli, Wolfgang Zimmermann, W. G. Kump, W. TOSCH, W. A. Vischer, O. Zák	1987	21
5	ChemInform Abstract: β‐LAPACHONE: SYNTHESIS OF DERIVATIVES AND ACTIVITIES IN TUMOR MODELS Chemischer Informationsdienst ·Faruk Ozcan Gozde Yesil Ilknur Ozcan, Snježanja KIrin, W. Wehrli, Alfred R. Schuerch, Jan W. F. Wasley	1985	14
6	Papulacandins - The relationship between chemical structure and effect on glucan synthesis in yeast. The Journal of Antibiotics ·G.Y. Osmanova, Peter Traxler, W. Wehrli	1983	38
7	Rifampin: Mechanisms of Action and Resistance Clinical Infectious Diseases ·W. Wehrli	1983	278
8	Investigation of the two final steps in the biosynthesis of cephalosporin C using permeabilized cells ofCephalosporium acremonium FEMS Microbiology Letters ·Hansruedi Felix, Ming Li Li, W. Wehrli	1980	16
9	Papulacandin B: an Inhibitor of Glucan Synthesis in Yeast Spheroplasts European Journal of Biochemistry ·Bruce C. Baguley, G.Y. Osmanova, J. Gruner, W. Wehrli	1979	108
10	Interaction between Rifampicin and DNA-dependent RNA Polymerase of E. coli Cold Spring Harbor Monograph Archive ·W. Wehrli, H. Elfenbaum, Werner Wunderli	1976	16
11	Fractionation of the nonpolar transfer ribonucleic acids from rat liver, yeast, and Escherichia coli by partition chromatography Biochemistry ·W. Wehrli, M. Staehelin	1971	11
12	Isolation and characterization of serine transfer ribonucleic acids from rat liver Biochemistry ·M. Staehelin, Peter Mueller, W. Wehrli	1971	21
13	Isolation of mammalian transfer RNA Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis ·H. Rogg, W. Wehrli, M. Staehelin	1969	113
14	Structure of a Mammalian Serine tRNA Nature ·M. Staehelin, H. Rogg, Bruce C. Baguley, T. Ginsberg, W. Wehrli	1968	130
15	Dismutation Reactions of Nucleoside Polyphosphates. II. Specific Chemical Syntheses of α-, β-, and γ-P³²-Nucleoside 5'-Triphosphates¹ Journal of the American Chemical Society ·W. Wehrli, Virinder S. Parma, J. G. Moffatt	1965	67
16	Die Cardenolide von Parquetina nigrescens (AFZEL) BULLOCK 3. Mitt. Die Konstitution 5 neuer Cardenolide (16‐Dehydrostrophanthidin und verwandte Substanzen). Glykoside und Aglykone, 271. Mitteilung [1] Helvetica Chimica Acta ·R. Berthold, W. Wehrli, T. Reichstein	1965	10
17	Dismutation Reactions of Nucleoside Polyphosphates. IV. A Mechanism for the Dismutation Reaction¹ Journal of the American Chemical Society ·W. Wehrli, J. G. Moffatt	1965	6
18	Die Cardenolide von Gongronema gazense (S. MOORE) BULLOCK. Zweite Mitteilung. Glykoside und Aglykone, 247. Mitteilung Helvetica Chimica Acta ·Marvin L. Lewbart, W. Wehrli, H. Kaufmann, T. Reichstein	1963	18
19	Die Glykoside des Milchsaftes von Antiaris toxicaria LESCH aus Bogor (Java). Glykoside und Aglykone, 243. Mitteilung Helvetica Chimica Acta ·Diksha Jain, W. Wehrli, T. Reichstein	1963	18
20	Die Glykoside des Milchsaftes von Antiaris toxicaria LESCH Konstitutionsermittlung von Malayosid und α‐Antiosid. Glykoside und Aglykone, 232. Mitteilung Helvetica Chimica Acta ·W. Wehrli	1962	15

About W. Wehrli

W. Wehrli is a scholar working on Molecular Medicine, Toxicology, Discrete Mathematics and Combinatorics, Biomaterials and Molecular Biology, having authored 48 papers that have together received 2.3k indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (9 papers), RNA and protein synthesis mechanisms (7 papers), Phytochemistry and Bioactive Compounds (7 papers), Microbial Natural Products and Biosynthesis (6 papers), Antibiotic Resistance in Bacteria (6 papers), Natural product bioactivities and synthesis (5 papers), Bacterial Genetics and Biotechnology (5 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Toxicology (169 citations), Molecular Medicine (223 citations), Molecular Biology (1.4k citations), Infectious Diseases (348 citations) and Pharmacology (290 citations). W. Wehrli has collaborated with scholars based in Switzerland, New Zealand and France. Frequent co-authors include M. Staehelin, F. Knüsel, H. Rogg, Bruce C. Baguley, Karl Schmid, Alfred R. Schuerch, T. Reichstein, J. Nüesch, J. G. Moffatt and J. Gruner. Their work appears in journals such as Helvetica Chimica Acta, Journal of the American Chemical Society, European Journal of Biochemistry, The Journal of Antibiotics and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact